Verum Health
Mitochondrial / Longevity Protocol

SS-31 / Elamipretide · 5ML

SS-31 (Elamipretide) is a mitochondria-targeted peptide studied for cardiolipin stabilization, ATP production, and protection against mitochondrial dysfunction. Physician-reviewed. Prescription required.

Longevity Performance Recovery Prescription Required
What It Is
SS-31 / Elamipretide 5ML

Mechanism of Action

SS-31 (elamipretide) is a mitochondria-targeted peptide designed to improve mitochondrial function, bioenergetics, and reduce oxidative stress. It physically associates with mitochondrial membranes and preserves electron transport chain (ETC) integrity.

SS-31 has been studied for its ability to maintain mitochondrial membrane integrity, enhance ATP production, reduce reactive oxygen species (ROS), and protect against mitochondrial permeability transition pore (mPTP) opening. It represents one of the most mechanistically targeted longevity compounds currently under investigation. Individual outcomes may differ. This protocol is not intended to diagnose, treat, cure, or prevent any disease.

Mechanism Biological Effect
Targeted mitochondrial localization Selective accumulation in mitochondria
Cardiolipin stabilization Maintains IMM structure and ETC integrity
Enhanced oxidative phosphorylation Improved ATP production
Reduced ROS generation Lower oxidative stress
Prevention of mPTP opening Protection against cell death
Anti-inflammatory signaling Reduced chronic inflammation
Neuroprotection Neuronal survival and reduced degeneration
Candidate Profile

Who It's Designed For

Your physician will determine eligibility based on your complete health intake. The following profiles are commonly associated with SS-31 / Elamipretide protocol candidates in clinical practice:

Mitochondrial Optimization

Individuals with mitochondrial decline or dysfunction seeking physician-supervised SS-31 support.

Cardiovascular Longevity

Individuals with cardiovascular health goals where mitochondrial membrane integrity may be clinically relevant.

Neurological Support

Individuals seeking physician-reviewed neuroprotective support through mitochondrial mechanisms.

Advanced Longevity Protocol

Individuals with established longevity protocols adding physician-reviewed mitochondrial targeting.

Determine your candidacy

A physician will review your intake and make eligibility determination within 24–48 hours.

Outcomes & Timeline

What the Clinical Literature Indicates

All outcome language below reflects what has been observed in clinical and preclinical settings. Individual outcomes may differ significantly. These are not guarantees.

Weeks 1–4
Early-stage signaling activity may be observed. Individual outcomes may differ. Physician monitoring recommended.
Weeks 4–8
In clinical and preclinical settings, progressive effects have been associated with continued administration. Results vary by individual.
Weeks 8–12
Sustained physician-supervised administration may support continued outcomes. Your physician will evaluate protocol continuation.
Dosing Overview

Protocol Structure

Dosing is determined individually by your assigned physician. The following represents typical ranges discussed in clinical literature. Do not self-administer or adjust dosing without physician guidance.

Typical Range

0.5–4 mg/day

Administration

Subcutaneous injection

Duration

Physician-determined cycles

Frequency

Daily to 3x weekly (physician-determined)

These ranges are indicative only. Your physician will prescribe the specific dose and schedule appropriate for your clinical profile.

What's Included

Your Protocol Package

Physician consultation — Virtual intake review and protocol consultation with your assigned NP/MD

Valid prescription — Issued by your attending physician upon protocol approval

Pharmacy-dispensed compound — Dispensed by our licensed 503A compounding pharmacy partner

Follow-up check-in — Physician review at protocol midpoint; reorder pathway established

Clinical Considerations

Contraindications & Safety Notes

Your physician will review your complete health history before determining eligibility. The following are commonly reviewed clinical considerations.

History of malignancy: Discuss with your physician. Angiogenic or growth-promoting peptides are reviewed carefully in cancer history contexts.
Pregnancy or lactation: Not indicated. Clinical use is contraindicated in pregnant or nursing individuals.
Current medications: Potential interactions reviewed during physician consultation. Disclose all medications and supplements during intake.
Autoimmune conditions: Reviewed case-by-case. Immunomodulating peptides require careful physician assessment.
FAQ

Common Questions

This compound is not FDA-approved as a drug. It is dispensed as a compounded medication through licensed 503A compounding pharmacies operating under FDA guidelines. All Verum Health protocols require a valid physician prescription.
After completing your HIPAA-secure health intake, a physician or NP will review your medical history, current medications, goals, and contraindications. If you're a candidate, a virtual consultation is scheduled — typically 15–20 minutes. Turnaround is 24–48 hours from intake submission.
Protocol stacking is reviewed on a case-by-case basis during your physician consultation. Any combination protocol is evaluated for safety and clinical appropriateness. Do not combine protocols without explicit physician guidance.
Reorders are managed through your patient portal. A follow-up physician check-in is required at protocol completion before continuation is authorized. Reorder notification is sent 10 days before your protocol completes.
SS-31 / Elamipretide
VERUM HEALTH
From $200
Prescription required
Begin Consultation
How it works:
Add to cart → complete physician intake → doctor reviews within 24–48h → approval → pharmacy ships direct.
Refill Policy: Approved protocols include 4 months of refills. Auto-refill available after initial approval.